1. What is Clinical and Molecular Allergy?
Clinical and Molecular Allergy publishes research on all clinical and molecular aspects of allergic (Type 1 hypersensitivity) and primary immunodeficiency disorders (diseases that alter host defense but are not related to Human Immunodeficiency Virus infection). Studies of allergic or hypersensitive aspects of HIV infection/AIDS or drug desensitization protocols in AIDS, however, fall into the journal’s scope.
All articles are available online, and in addition the website offers many other services:
- Quick and advanced search facilities.
- RSS feed, to deliver our latest articles directly to your news headline reader.
- Email articles directly to your friends and colleagues.
- Post a comment on an article, to add your opinion.
For details of the scope and types of article published by Clinical and Molecular Allergy see About Clinical and Molecular Allergy
- What is Clinical and Molecular Allergy?
- Why submit to Clinical and Molecular Allergy?
- What is Open Access?
- If my article is published, how will it be cited?
- If my article is published, which bibliographic databases will it be indexed in?
- How can I order reprints?
- What is the copyright policy of Clinical and Molecular Allergy?
- Do I need permission to reproduce materials published in Clinical and Molecular Allergy?
- What are the benefits of registering on the journal website?
- Is there a printed version of the journal?
- How can I ensure that I receive Clinical and Molecular Allergy's emails?
- What is BioMed Central?
